More on CSBR
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $6.10 |
|
|||
| Open | $6.10 | ||||
| 52 Wk High | $4.60 | ||||
| 52 Wk Low | $1.11 | ||||
| Day High | $6.10 | ||||
| Day Low | $6.10 | ||||
| P/E | N/A | ||||
| EPS | $-0.20 | ||||
| Volume | 285,587 | ||||
- Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Monday, July 27, 2026
- Champions Oncology to present research findings at AACR 2026 conference
- Champions Oncology to Present New Data on Predicting Response and Resistance at AACR 2026
- Form 8-K CHAMPIONS ONCOLOGY, INC. For: Mar 24
- Champions Oncology appoints Brian Alexander to board of directors
- Champions Oncology Names Brian Alexander to Board as Company Advances Data-Driven Oncology Strategy
- Form 10-Q CHAMPIONS ONCOLOGY, INC. For: Jan 31
- Champions Oncology (CSBR) Misses Q3 EPS by 4c
- Form 8-K CHAMPIONS ONCOLOGY, INC. For: Mar 12
- Champions Oncology reports Q3 revenue of $16.6 million
Entities mentioned with CSBR
- Earnings | View Related Stories »
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- Twitter | View Related Stories »
- 13D | View Related Stories »
- 13G | View Related Stories »
- S1 | View Related Stories »
- Show More...
